[Skip to Content]
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
[Skip to Content Landing]



December 28, 2016
Original Investigation

Association of Fenofibrate Therapy With Long-term Cardiovascular Risk in Statin-Treated Patients With Type 2 Diabetes

Abstract Full Text
JAMA Cardiol. Published online December 28, 2016. doi:10.1001/jamacardio.2016.4828

This follow-up study of the ACCORD lipid trial examines whether fenofibrate is associated with reduced cardiovascular risk in statin-treated patients with type 2 diabetes.